arrow
G

Giacomo P. Comi

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
H指数:92
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High Prevalence of SOD1 Pathogenic Variants in the UK Biobank: Implications for Early Intervention in Amyotrophic Lateral Sclerosis

英国生物银行中SOD1致病性变异的高患病率:对肌萎缩侧索硬化症早期干预的启示

2026-03-190
OAAI
AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model

AAV9基因治疗在SMARD1/CMT2S中的优化:在SMARD1临床前模型中两种载体的安全性与长期疗效比较

2026-01-040
OAAI
Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids

靶向反义寡核苷酸治疗可挽救脊髓性肌萎缩症类器官中的发育改变

2025-12-210
OAAI
Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies
2025-12-010
OAAI
Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathy

POPDC2基因的杂合变异导致一种常染色体隐性综合征,其表现为心脏传导缺陷和肥厚型心肌病。

2025-05-220
OA
Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T

COL6相关严重型肌营养不良的表征:由复发性变异COL6A1 c.930+189C>T引起

Brain
IF11.7
2025-04-030
OA
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey

意大利杜氏肌营养不良症的患病率: 一项全国性调查

2024-12-160
PRE
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease
2024-09-041
OA
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies Experience From the Italian Network
2024-08-271
PRE